Omnicell reports Q3 non-GAAP EPS 56c, consensus 40c

Reports Q3 revenue $282.42M, consensus $280.45M. Randall Lipps, chairman, president, CEO, said, “We are pleased to deliver another consecutive quarter of solid financial performance, with results within or exceeding each of our previously issued guidance ranges. As the macroeconomic environment within the healthcare sector continues to show signs of stabilization, we believe our outcomes-centric innovation and customer-first focus is resonating with the market.”